Earnings Outlook For scPharmaceuticals
Portfolio Pulse from Benzinga Insights
scPharmaceuticals (NASDAQ:SCPH) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.37. The company's past performance shows a pattern of beating EPS estimates, but this has sometimes been followed by a drop in share price. The stock is currently trading at $7.88 and has seen a 32.57% increase over the last 52-week period.
August 09, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
scPharmaceuticals is expected to report an EPS of $-0.37. Despite past EPS beats, the share price has sometimes dropped. The stock has increased by 32.57% over the last 52 weeks.
The company's earnings report is a key event that could impact its stock price. While the company has a history of beating EPS estimates, this has sometimes led to a drop in share price. However, the stock has been performing well over the past year, which could indicate investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100